Join
Live feed
·
INSIDERFilingvia Quantisnow
NewAmsterdam Pharma Company N.V. logo

Chief Accounting Officer Kooij Louise Frederika converted options into 18,073 units of Ordinary Shares, increasing direct ownership by 120% to 33,073 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAMS (NewAmsterdam Pharma Company N.V.) and more on Quantisnow.